Understanding how epigenetic factors influence prostate cancer
Towards characterization of Epigenetic targets in Prostate Cancer
This study is looking at how advanced prostate cancer becomes resistant to certain treatments, and it aims to find new ways to help improve care for patients dealing with this tough condition by exploring how specific proteins interact with the cancer cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11105090 on NIH RePORTER |
What this research studies
This research focuses on advanced prostate cancer, particularly how cancer cells become resistant to treatments that target the androgen receptor (AR). It aims to identify and characterize specific proteins and cofactors that interact with AR, which may contribute to the progression of the disease. By understanding these mechanisms, the research seeks to develop new therapeutic strategies that could improve treatment outcomes for patients with metastatic castration-resistant prostate cancer. The study will involve laboratory experiments and analysis of cancer cell behavior in response to various treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with advanced prostate cancer, especially those experiencing resistance to androgen-targeted therapies.
Not a fit: Patients with early-stage prostate cancer or those who have not undergone androgen-targeted treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for men with advanced prostate cancer, particularly those who have developed resistance to current therapies.
How similar studies have performed: Previous research has shown promising results in targeting epigenetic factors in cancer treatment, indicating that this approach could be beneficial.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Asangani, Irfan Ahmed — University of Pennsylvania
- Study coordinator: Asangani, Irfan Ahmed
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.